CVS looks to 2023 after opioids settlement, Medicare rating decline
Go back to CVS looks to 2023 after opioids settlement, Medicare rating decline| CVS Caremark Corp. (NYSE: CVS) | Delayed: 91.32 -0.4 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $91.72 | 52 Week High | $106.67 | |||
| Open | $92.00 | 52 Week Low | $69.30 | |||
| Day High | $92.14 | P/E | 24.35 | |||
| Day Low | $90.90 | EPS | $3.75 | |||
| Volume | 1,986,770 | |||||

